APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intercellular Adhesion Molecule 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intercellular Adhesion Molecule 1 Industry Growth and Trends Forecast to 2032

26 December 202572 pages

Choose your research edition.

Industry ResearchIntercellular Adhesion Molecule 1 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Intercellular Adhesion Molecule 1 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Intercellular Adhesion Molecule 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intercellular Adhesion Molecule 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Intercellular Adhesion Molecule 1 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Intercellular Adhesion Molecule 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intercellular Adhesion Molecule 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intercellular Adhesion Molecule 1 include RXi Pharmaceuticals Corp, China Medical System Holdings Ltd and Atlantic Healthcare Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intercellular Adhesion Molecule 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intercellular Adhesion Molecule 1 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intercellular Adhesion Molecule 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intercellular Adhesion Molecule 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intercellular Adhesion Molecule 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intercellular Adhesion Molecule 1 Market by Company

RXi Pharmaceuticals Corp

China Medical System Holdings Ltd

Atlantic Healthcare Plc

Intercellular Adhesion Molecule 1 Segment by Type

CMS-024

DNP-003

MS-553

Others

Intercellular Adhesion Molecule 1 Segment by Application

Genito Urinary System and Sex Hormones

Dermatology

Crohn's Disease

Others

Intercellular Adhesion Molecule 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intercellular Adhesion Molecule 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intercellular Adhesion Molecule 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intercellular Adhesion Molecule 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intercellular Adhesion Molecule 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intercellular Adhesion Molecule 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CMS-024 Table 2. Major Company of DNP-003 Table 3. Major Company of MS-553 Table 4. Major Company of Others Table 5. Global Intercellular Adhesion Molecule 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 7. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type (2021-2026) Table 10. Global Intercellular Adhesion Molecule 1 Price by Type (2021-2026) & (US$/Unit) Table 11. Global Intercellular Adhesion Molecule 1 Sales by Type (2027-2032) & (W Units) Table 12. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Intercellular Adhesion Molecule 1 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type (2027-2032) Table 15. Global Intercellular Adhesion Molecule 1 Price by Type (2027-2032) & (US$/Unit) Table 16. North America Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 17. North America Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 19. Europe Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 23. Latin America Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Type (2021-2026) & (US$ Million) Table 26. Intercellular Adhesion Molecule 1 Industry Trends Table 27. Intercellular Adhesion Molecule 1 Industry Drivers Table 28. Intercellular Adhesion Molecule 1 Industry Opportunities and Challenges Table 29. Intercellular Adhesion Molecule 1 Industry Restraints Table 30. Global Intercellular Adhesion Molecule 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Intercellular Adhesion Molecule 1 Revenue Market Share by Company (2021-2026) Table 32. Global Intercellular Adhesion Molecule 1 Sales by Company (2021-2026) & (W Units) Table 33. Global Intercellular Adhesion Molecule 1 Sales Share by Company (2021-2026) Table 34. Global Intercellular Adhesion Molecule 1 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Intercellular Adhesion Molecule 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Intercellular Adhesion Molecule 1 Major Company Production Sites and Headquarters Table 37. Global Intercellular Adhesion Molecule 1 Company, Product Type & Application Table 38. Global Intercellular Adhesion Molecule 1 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Intercellular Adhesion Molecule 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Intercellular Adhesion Molecule 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Intercellular Adhesion Molecule 1 Sales by Region (2021-2026) & (W Units) Table 43. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Intercellular Adhesion Molecule 1 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Region (2021-2026) Table 46. Global Intercellular Adhesion Molecule 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Intercellular Adhesion Molecule 1 Sales by Region (2027-2032) & (W Units) Table 48. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Intercellular Adhesion Molecule 1 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Region (2027-2032) Table 51. Global Intercellular Adhesion Molecule 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Intercellular Adhesion Molecule 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 54. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application (2021-2026) Table 57. Global Intercellular Adhesion Molecule 1 Price by Application (2021-2026) & (US$/Unit) Table 58. Global Intercellular Adhesion Molecule 1 Sales by Application (2027-2032) & (W Units) Table 59. Global Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Intercellular Adhesion Molecule 1 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application (2027-2032) Table 62. Global Intercellular Adhesion Molecule 1 Price by Application (2027-2032) & (US$/Unit) Table 63. North America Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 64. North America Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 66. Europe Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 70. Latin America Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Application (2021-2026) & (US$ Million) Table 73. RXi Pharmaceuticals Corp Company Information Table 74. RXi Pharmaceuticals Corp Business Overview Table 75. RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Product Portfolio Table 77. RXi Pharmaceuticals Corp Recent Development Table 78. China Medical System Holdings Ltd Company Information Table 79. China Medical System Holdings Ltd Business Overview Table 80. China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Product Portfolio Table 82. China Medical System Holdings Ltd Recent Development Table 83. Atlantic Healthcare Plc Company Information Table 84. Atlantic Healthcare Plc Business Overview Table 85. Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Product Portfolio Table 87. Atlantic Healthcare Plc Recent Development Table 88. North America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 89. North America Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 90. North America Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 91. North America Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032) & (W Units) Table 92. North America Intercellular Adhesion Molecule 1 Sales Market Share Forecast by Country (2027-2032) Table 93. North America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Intercellular Adhesion Molecule 1 Market Share by Country (2021-2026) Table 96. North America Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Intercellular Adhesion Molecule 1 Market Share Forecast by Country (2027-2032) Table 98. Europe Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 99. Europe Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 100. Europe Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 101. Europe Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032) & (W Units) Table 102. Europe Intercellular Adhesion Molecule 1 Sales Market Share Forecast by Country (2027-2032) Table 103. Europe Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Intercellular Adhesion Molecule 1 Market Share by Country (2021-2026) Table 106. Europe Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Intercellular Adhesion Molecule 1 Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 110. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 111. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032) & (W Units) Table 112. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Intercellular Adhesion Molecule 1 Market Share by Country (2021-2026) Table 116. Asia-Pacific Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Intercellular Adhesion Molecule 1 Market Share Forecast by Country (2027-2032) Table 118. Latin America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Latin America Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 120. Latin America Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 121. Latin America Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032) & (W Units) Table 122. Latin America Intercellular Adhesion Molecule 1 Sales Market Share Forecast by Country (2027-2032) Table 123. Latin America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Intercellular Adhesion Molecule 1 Market Share by Country (2021-2026) Table 126. Latin America Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Intercellular Adhesion Molecule 1 Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Country (2021-2026) & (W Units) Table 130. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share by Country (2021-2026) Table 131. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032) & (W Units) Table 132. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East and Africa Intercellular Adhesion Molecule 1 Market Share by Country (2021-2026) Table 136. Middle East and Africa Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Intercellular Adhesion Molecule 1 Market Share Forecast by Country (2027-2032) Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Intercellular Adhesion Molecule 1 Distributors List Table 141. Intercellular Adhesion Molecule 1 Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Intercellular Adhesion Molecule 1 Image Figure 2. Global Intercellular Adhesion Molecule 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intercellular Adhesion Molecule 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Intercellular Adhesion Molecule 1 Sales (2021-2032) & (W Units) Figure 5. CMS-024 Image Figure 6. Global CMS-024 Sales YoY Growth (2021-2032) & (W Units) Figure 7. DNP-003 Image Figure 8. Global DNP-003 Sales YoY Growth (2021-2032) & (W Units) Figure 9. MS-553 Image Figure 10. Global MS-553 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Intercellular Adhesion Molecule 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Intercellular Adhesion Molecule 1 Market Share by Type 2025 VS 2032 Figure 15. North America Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type in 2025 Figure 16. North America Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type in 2025 Figure 17. Europe Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Intercellular Adhesion Molecule 1 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Genito Urinary System and Sex Hormones Image Figure 28. Global Genito Urinary System and Sex Hormones Sales YoY Growth (2021-2032) & (W Units) Figure 29. Dermatology Image Figure 30. Global Dermatology Sales YoY Growth (2021-2032) & (W Units) Figure 31. Crohn's Disease Image Figure 32. Global Crohn's Disease Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Intercellular Adhesion Molecule 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Intercellular Adhesion Molecule 1 Market Share by Application 2025 VS 2032 Figure 37. North America Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application in 2025 Figure 38. North America Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application in 2025 Figure 39. Europe Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Market Share in Value by Application in 2025 Figure 47. North America Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Intercellular Adhesion Molecule 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Intercellular Adhesion Molecule 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Intercellular Adhesion Molecule 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Intercellular Adhesion Molecule 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Intercellular Adhesion Molecule 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Intercellular Adhesion Molecule 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Intercellular Adhesion Molecule 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Intercellular Adhesion Molecule 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Intercellular Adhesion Molecule 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Intercellular Adhesion Molecule 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Intercellular Adhesion Molecule 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Intercellular Adhesion Molecule 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Intercellular Adhesion Molecule 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Intercellular Adhesion Molecule 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Intercellular Adhesion Molecule 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Intercellular Adhesion Molecule 1 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Intercellular Adhesion Molecule 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CMS-024
  • DNP-003
  • MS-553
  • Others
Applications
  • Genito Urinary System and Sex Hormones
  • Dermatology
  • Crohn's Disease
  • Others
Companies covered
  • RXi Pharmaceuticals Corp
  • China Medical System Holdings Ltd
  • Atlantic Healthcare Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intercellular Adhesion Molecule 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intercellular Adhesion Molecule 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intercellular Adhesion Molecule 1 Market by Type
  6. 1.3.1 CMS-024
  7. 1.3.2 DNP-003
  8. 1.3.3 MS-553
  9. 1.3.4 Others
  10. 1.4 Global Intercellular Adhesion Molecule 1 Market Size by Type
  11. 1.4.1 Global Intercellular Adhesion Molecule 1 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Intercellular Adhesion Molecule 1 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Intercellular Adhesion Molecule 1 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Intercellular Adhesion Molecule 1 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Intercellular Adhesion Molecule 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Intercellular Adhesion Molecule 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Intercellular Adhesion Molecule 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intercellular Adhesion Molecule 1 Industry Trends
  2. 2.2 Intercellular Adhesion Molecule 1 Industry Drivers
  3. 2.3 Intercellular Adhesion Molecule 1 Industry Opportunities and Challenges
  4. 2.4 Intercellular Adhesion Molecule 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intercellular Adhesion Molecule 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Intercellular Adhesion Molecule 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Intercellular Adhesion Molecule 1 Price (2021-2026)
  4. 3.4 Global Intercellular Adhesion Molecule 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intercellular Adhesion Molecule 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Intercellular Adhesion Molecule 1 Company, Product Type & Application
  7. 3.7 Global Intercellular Adhesion Molecule 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intercellular Adhesion Molecule 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intercellular Adhesion Molecule 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intercellular Adhesion Molecule 1 Tier 1, Tier 2, and Tier 3
4 Intercellular Adhesion Molecule 1 Regional Status and Outlook
  1. 4.1 Global Intercellular Adhesion Molecule 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intercellular Adhesion Molecule 1 Historic Market Size by Region
  3. 4.2.1 Global Intercellular Adhesion Molecule 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intercellular Adhesion Molecule 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intercellular Adhesion Molecule 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intercellular Adhesion Molecule 1 Forecasted Market Size by Region
  7. 4.3.1 Global Intercellular Adhesion Molecule 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intercellular Adhesion Molecule 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intercellular Adhesion Molecule 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intercellular Adhesion Molecule 1 by Application
  1. 5.1 Intercellular Adhesion Molecule 1 Market by Application
  2. 5.1.1 Genito Urinary System and Sex Hormones
  3. 5.1.2 Dermatology
  4. 5.1.3 Crohn's Disease
  5. 5.1.4 Others
  6. 5.2 Global Intercellular Adhesion Molecule 1 Market Size by Application
  7. 5.2.1 Global Intercellular Adhesion Molecule 1 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Intercellular Adhesion Molecule 1 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Intercellular Adhesion Molecule 1 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Intercellular Adhesion Molecule 1 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Intercellular Adhesion Molecule 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Intercellular Adhesion Molecule 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Intercellular Adhesion Molecule 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 RXi Pharmaceuticals Corp
  2. 6.1.1 RXi Pharmaceuticals Corp Company Information
  3. 6.1.2 RXi Pharmaceuticals Corp Business Overview
  4. 6.1.3 RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 RXi Pharmaceuticals Corp Intercellular Adhesion Molecule 1 Product Portfolio
  6. 6.1.5 RXi Pharmaceuticals Corp Recent Developments
  7. 6.2 China Medical System Holdings Ltd
  8. 6.2.1 China Medical System Holdings Ltd Company Information
  9. 6.2.2 China Medical System Holdings Ltd Business Overview
  10. 6.2.3 China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 China Medical System Holdings Ltd Intercellular Adhesion Molecule 1 Product Portfolio
  12. 6.2.5 China Medical System Holdings Ltd Recent Developments
  13. 6.3 Atlantic Healthcare Plc
  14. 6.3.1 Atlantic Healthcare Plc Company Information
  15. 6.3.2 Atlantic Healthcare Plc Business Overview
  16. 6.3.3 Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Atlantic Healthcare Plc Intercellular Adhesion Molecule 1 Product Portfolio
  18. 6.3.5 Atlantic Healthcare Plc Recent Developments
7 North America by Country
  1. 7.1 North America Intercellular Adhesion Molecule 1 Sales by Country
  2. 7.1.1 North America Intercellular Adhesion Molecule 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intercellular Adhesion Molecule 1 Market Size by Country
  6. 7.2.1 North America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intercellular Adhesion Molecule 1 Sales by Country
  2. 8.1.1 Europe Intercellular Adhesion Molecule 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intercellular Adhesion Molecule 1 Market Size by Country
  6. 8.2.1 Europe Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Country
  2. 9.1.1 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intercellular Adhesion Molecule 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intercellular Adhesion Molecule 1 Sales by Country
  2. 10.1.1 South America Intercellular Adhesion Molecule 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intercellular Adhesion Molecule 1 Market Size by Country
  6. 10.2.1 South America Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Country
  2. 11.1.1 Middle East and Africa Intercellular Adhesion Molecule 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intercellular Adhesion Molecule 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intercellular Adhesion Molecule 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intercellular Adhesion Molecule 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Intercellular Adhesion Molecule 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intercellular Adhesion Molecule 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intercellular Adhesion Molecule 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intercellular Adhesion Molecule 1 Value Chain Analysis
  2. 12.1.1 Intercellular Adhesion Molecule 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intercellular Adhesion Molecule 1 Production Mode & Process
  7. 12.2 Intercellular Adhesion Molecule 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intercellular Adhesion Molecule 1 Distributors
  10. 12.2.3 Intercellular Adhesion Molecule 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst